Diatec Diabetes, based in Memphis, TN, is developing SmartFusion: a system for insulin pumps that monitors insulin delivery for accuracy and infusion set failure. SmartFusion's software could be integrated into an insulin pump or app and use data from the pump, continuous glucose monitor, and patient infusion habits to monitor the success of daily insulin dosages.

THE PROBLEM: Insulin infusions are administered through subcutaneous tissue. Repeated insertions and chronic insulin exposure compromises the subcutaneous tissue under the skin. The changes in subcutaneous tissue can lead to infusion site abnormalities, which could reduce the efficacy of the insulin being used and lead to hazardous consequences to those living with this diabetes.

THE SOLUTION: SmartFusion: a system for insulin pumps that monitors insulin delivery for accuracy and infusion set failure

The management team includes John Wilcox, CEO and T1D, Luis Blanco, CTO, JC Gray, CSO, and Nick Cooper COO, who all met at Florida State University

Advisors include Dr. Rayhan Lal (Stanford endocrinology & T1D) and Dave Walton (T1D Exchange and T1D)

“Insulin delivery done right”

свернуть